Infection with Chlamydia pneumoniae occurs worldwide, resulting in a 40-90% prevalence of serum antibody to the species in various populations. Serology is the most commonly used diagnostic tool for the detection of respiratory chlamydial infections in routine clinical practice. The major issue of this study is the validity of the tests used, especially the new rDNA LPS ELISA.
|Translated title of the contribution||Micro-immuno fluorescence for the diagnosis of infectious disease|
|Number of pages||5|
|Publication status||Published - 20 Jul 2019|
- Infectious disease
- Micro-immuno fluorescence